Frontlight ResearchEarly access
What researchers published on Pancreatic cancer
55,828 papers, newest first.
Showing 40 of 55,828
Reply to the Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
ASO Visual Abstract: Prognostic Impact of the Combined Use of CA19-9 and DUPAN-2 in Initially Unresectable Locally Advanced Pancreatic Adenocarcinoma.Annals of surgical oncology
High-Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study.United European gastroenterology journal
Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer.Molecular therapy. Oncology
Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ACSL5 suppresses pancreatic cancer progression and gemcitabine resistance by regulating n-6 docosapentaenoic acid metabolism.Cell death & disease
ReviewTumor-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
ReviewUnifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.Molecular cancer
Review[Research progress of irreversible electroporation for pancreatic cancer].Zhonghua nei ke za zhi
Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Schisandrin B Suppresses Pancreatic Ductal Adenocarcinoma Through EGFR/AKT/mTOR Signaling and Mitochondrial Dysfunction.International journal of molecular sciences
ReviewSynergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.Cancers
Activity of Fluoro-Substituted 3,5-Di[(E)-Benzylidene]piperidin-4-Ones with N-Arylsulfonyl Appendages Against KRAS-Mutant Pancreatic Ductal Adenocarcinoma Cells.International journal of molecular sciences
ReviewCirculating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.Cancers
ReviewTreatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.Cancers
Yellow, Red, and Black Lepidium meyenii Preparations Differentially Modulate Doxorubicin Response and Lipid Metabolism-Related Changes in Pancreatic Cancer Cells.Molecules (Basel, Switzerland)
Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy.Cancers
ReviewThe Association Between Asthma and Pancreatic Cancer: A Systematic Review.Cancers
OTI1H1-Defined MAGEA3-Directed Immunoreactivity and Survival in Pancreatic Ductal Adenocarcinoma: A Single-Center Study.Journal of clinical medicine
Cellularity Improvement of EUS-FNB Specimens for Pancreatic Adenocarcinoma Using a Cell-Capturing Scaffold.Journal of clinical medicine
Tissue miR-143 and miR-29b Expression as Prognostic Biomarkers in Patients with Resected Pancreatic Ductal Adenocarcinoma Receiving Adjuvant Chemotherapy.Diagnostics (Basel, Switzerland)
The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.Cancers
Kynureninase Is a Prognostic Biomarker of Poor Survival and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences
Targeting ELF3 with Biomimetic Nanotherapy Sensitizes PDAC to Gemcitabine via GSDME-mediated Pyroptosis.Pharmacological research
LncRNA signatures associated with exhausted CD8⁺T cells for assessing the immune microenvironment and drug sensitivity in pancreatic adenocarcinoma.Neoplasia (New York, N.Y.)
Explainable artificial intelligence identifies circulating microRNA candidate biomarkers for liquid biopsy-based pancreatic cancer detection.Frontiers in artificial intelligence
Simple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC).Cancers
ReviewFood Environment, Food Access, and Disparities in Pancreatic Cancer Outcomes: A Narrative Review of Evidence Gaps and Future Directions.Nutrients
ReviewPeriodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.Journal of oral microbiology
ReviewChanging Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.International journal of molecular sciences
Hydrophobic ion pairing enabled self-nanoemulsifying niclosamide for pancreatic cancer: improved drug loading and kinetic solubility.International journal of pharmaceutics
Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.Current cancer drug targets
Depletion of Endogenous IL-18 Suppresses Pancreatic Cancer Progression, Reprograms the Tumor Microenvironment, and Enhances KRAS Inhibitor Efficacy.Gastroenterology
PRMT1 blockade reverts resistance to KRAS (G12C) inhibition through modulating ferroptosis signalling.International journal of oncology
A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.HPB : the official journal of the International Hepato Pancreato Biliary Association
Radical antegrade modular pancreatosplenectomy versus conventional distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma: a multicenter propensity score-matched analysis.Annals of surgical treatment and research
ReviewImmune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies.Frontiers in immunology
Case reportRecurrent Multi-territory Thromboembolism As the Initial Presentation of Pancreatic Adenocarcinoma and Suspected Nonbacterial Thrombotic Endocarditis.Cureus
Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar.Annals of surgery